Biological treatments for severe asthma: A major advance in asthma care

Allergology International : Official Journal of the Japanese Society of Allergology
William W Busse

Abstract

Asthma is a heterogeneous disease with considerable variability noted in disease severity, patterns of airway inflammation, and achievement of disease control on current medications. An absence of disease control is most frequently noted in patients with severe asthma, and is defined as a lack of control while on high dose inhaled corticosteroids (ICS) plus a second controller medication. In part, this lack of control may relate to a diminished effect of current guideline-directed care on the existing pattern of airway inflammation in severe asthma. Airway inflammation in severe asthma has been arbitrarily divided into T (type) 2 high and T2 low. T2 high is characterized by the generation of key cytokines, interleukin (IL)-4, -5 and -13, which generate and regulate airway inflammation. Biomarkers to mark the presence of T2-high inflammation include eosinophils, fractional exhaled nitric oxide (FeNO) and immunoglobulin (Ig) E, whose presence arises from the action of IgE, IL-5, IL-4, and IL-13. In this review, treatment of severe asthma with monoclonal antibodies, i.e. biologics, which are directed against these inflammation generated pathways are reviewed. The available monoclonal antibodies include omalizumab (anti-IgE); mepol...Continue Reading

Citations

Sep 11, 2019·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Hani Harb, Talal A Chatila
Aug 20, 2019·Expert Review of Clinical Immunology·Carlo CavaliereCristoforo Incorvaia
Nov 16, 2019·Drugs·Emma D Deeks
Jan 10, 2020·Expert Opinion on Biological Therapy·Angela Moran, Ian D Pavord
Feb 12, 2020·JAMA : the Journal of the American Medical Association·Edward M Zoratti, George T O'Connor
Jan 18, 2020·The European Respiratory Journal·Andrew Menzies-GowChristopher E Brightling
Jun 23, 2020·Expert Opinion on Therapeutic Targets·Izabela GalvãoPhilip M Hansbro
May 28, 2020·Expert Opinion on Pharmacotherapy·Alessandro VatrellaCarolina Vitale
Jan 21, 2020·Expert Opinion on Pharmacotherapy·Timothy E AlbertsonSusan Murin
Jul 28, 2020·Archives of Disease in Childhood·Ian P SinhaJustus Simba
Jul 28, 2019·Calcified Tissue International·Karen MaesGhislaine Gayan-Ramirez
Aug 16, 2019·Expert Review of Respiratory Medicine·Federica PorcaroGiovanni Battista Pajno
Jan 31, 2020·European Respiratory Review : an Official Journal of the European Respiratory Society·Michal ShteinbergJames D Chalmers
Nov 30, 2019·Italian Journal of Pediatrics·Mattia GiovanniniElio Novembre
Feb 16, 2020·Seminars in Immunopathology·Michael Kabesch, Jörg Tost
May 21, 2020·Current Allergy and Asthma Reports·Katherine L TisonMichael S Blaiss
Sep 17, 2020·Allergy, Asthma & Immunology Research·Byung Keun KimUNKNOWN Korean Academy of Asthma, Allergy, and Clinical Immunology (KAACI), the Working Group on Severe Asthma
Sep 12, 2020·Yeungnam University Journal of Medicine·Hyun Jung Jin
Oct 25, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Steffi M J JanssenAlex J van 't Hul
Dec 22, 2020·Terapevticheskiĭ arkhiv·G L IgnatovaS A Kochetkova
Oct 4, 2020·The European Respiratory Journal·Ciaran O'NeillJodie L Simpson
Oct 2, 2020·The World Allergy Organization Journal·Giorgio Walter CanonicaUNKNOWN SANI (Severe Asthma Network Italy)
Feb 20, 2021·Scandinavian Journal of Immunology·Laura BergantiniElena Bargagli
Apr 25, 2021·Respiratory Investigation·Norihiro HaradaKazuhisa Takahashi
Jul 1, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Manon GrandbastienFrédéric de Blay
Jun 25, 2021·Journal of Asthma and Allergy·Charlene M PrazmaSteven W Yancey
Jul 6, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Hao ZhuYongfang Yuan
Feb 6, 2021·The European Respiratory Journal·William W BusseMario Castro
Jul 31, 2021·Expert Opinion on Biological Therapy·Konstantinos KatsoulisStelios Loukides
Jul 15, 2020·Current Medicinal Chemistry·Giovanni RollaAndrei Malinovschi
Oct 5, 2021·Experimental and Therapeutic Medicine·Ariadna Petronela FildanDoina Tofolean
Nov 12, 2021·Expert Review of Clinical Immunology·Francesco MenzellaNicola Facciolongo
Nov 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Roland BuhlMonica Kraft
Dec 11, 2021·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Patricia Mir-IharaSantiago Quirce
Dec 25, 2021·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Elliot IsraelRafael Alfonso-Cristancho
Jan 8, 2022·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Liang LiHongmei Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Current Opinion in Allergy and Clinical Immunology
William W Busse
Allergologia et immunopathologia
S QuirceP Barranco
Deutsche medizinische Wochenschrift
Marek Lommatzsch
© 2022 Meta ULC. All rights reserved